Prognostic Impact of Delta-haemolysin Production Deficiency in Staphylococcus Aureus on the Prognosis of Infected Implant Treated by DAIR
NCT ID: NCT03796104
Last Updated: 2023-04-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2018-01-01
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Implant-Associated P. Aeruginosa Bone And Joint Infections : Experience In A Regional Reference Center In France
NCT03624855
Outcome of Old Patient With Articular With Articular Implant Infection
NCT05284331
Short vs. Long Antibiotic Treatment of Implant-free Osteoarticular Infections
NCT03602209
The Influence of Implant Position on the Occurrence of Biological Complications
NCT05358782
Lyon PJI Retrospective Cohort Study
NCT04722926
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Deficiency of delta-hemolysine
Implant infected by Staphylococcus aureus with delta-haemolysin Production Deficiency
Delta-haemolysin
comparison of groups having infection with S. aureus with and without delta-haemolysin Production
Presence of delta-hemolysine
Implant infected by Staphylococcus aureus with delta-haemolysin Production
Delta-haemolysin
comparison of groups having infection with S. aureus with and without delta-haemolysin Production
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Delta-haemolysin
comparison of groups having infection with S. aureus with and without delta-haemolysin Production
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eugénie MABRUT
clinical research assistant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
FLORENT VALOUR, Md,PhD
Role: PRINCIPAL_INVESTIGATOR
Hospices Civils de Lyon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospices Civils de Lyon
Lyon, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Eugenie Mabrut, CRA
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18-333
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.